NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Wednesday, May 9th. Shareholders of record on Monday, July 2nd will be paid a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 annualized dividend and a yield of 3.90%. The ex-dividend date of this dividend is Friday, June 29th. This is a boost from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health declared that its board has initiated a stock repurchase program on Thursday, February 8th 2018, which permits the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's leadership believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) issued its earnings results on Thursday, May, 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.51 by $0.12. The business had revenue of $33.63 billion for the quarter, compared to analysts' expectations of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus estimate of $5.42.

15 brokers have issued 12 month target prices for Cardinal Health's stock. Their predictions range from $40.00 to $81.00. On average, they anticipate Cardinal Health's share price to reach $64.8571 in the next year. This suggests a possible upside of 32.9% from the stock's current price. View Analyst Ratings for Cardinal Health.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

News stories about CAH stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardinal Health earned a news impact score of 0.15 on Accern's scale. They also assigned media stories about the company an impact score of 46.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Cardinal Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Hexavest Inc. (0.30%), Deprince Race & Zollo Inc. (0.14%), Bank of Montreal Can (0.09%), Howard Capital Management Inc. (0.07%), Retirement Systems of Alabama (0.05%) and Denali Advisors LLC (0.04%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Hexavest Inc., Hartford Investment Management Co., Huntington National Bank, Nippon Life Global Investors Americas Inc., Retirement Systems of Alabama, Nisa Investment Advisors LLC and Riverbridge Partners LLC. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was acquired by a variety of institutional investors in the last quarter, including Capital Investment Advisors LLC, Howard Capital Management Inc., Deprince Race & Zollo Inc., Whittier Trust Co., Cornerstone Wealth Management LLC, State of Alaska Department of Revenue, Regent Investment Management LLC and Kempner Capital Management Inc.. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $48.80.

Cardinal Health has a market capitalization of $15.16 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]